Click to Share
  1. Latest News
  2. Submit Press Release

drug development Press Releases

  + XML/RSS  

By PATH OneWorld Health
PATH's Drug Development program has developed a new medication to treat diarrhea. This new drug treats the diarrheal process to shorten its duration.
By Rosa & Co
Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on November 14, 2012.
By Rosa & Co
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process at 4th World PK/PD Summit on November 28, 2012 in Frankfort, Germany
By Cambridge Healthtech Institute
Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development
By Arrowhead Publishers and Conferences
The 2nd Annual Drug Repositioning and Indications Discovery Conference is being held on October 23-24, 2012 in San Francisco, CA. This conference will feature a variety of speakers from academia, industry, non-profits and government.
By kdm communications
Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market
By World Trade Group
We’re pleased to announce that Andreas Schneider, Vice President Life Science Alliances, Roche, will be speaking at the Early Drug Development Summit, 3rd - 4th December 2012 at the Hotel Palace Berlin, Germany.
By Cambridge Healthtech Institute
Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development.
By Rosa & Co
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012
By Mary Ann Liebert, Inc., publishers
The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds.
By ICRC-Weyer GmbH
Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation.
By Biotech Support Group
Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification
By Biotech Support Group
UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples
By Biotech Support Group
NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins.
By OneWorld Health/PATH
Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader.
By Biotech Support Group
Hemoglobin Depletion Plus Protein Enrichment From Dried Blood Spot (Blood Card) Technology
By Biotech Support Group
Signup to attend protein enrichment webinar series to explore proteomics and genomic sample preparation products and research featuring albumin depletion, urine protein enrichment, glycoproteins enrichment.
By CRC Press
Covers the regulatory requirements, scientific and practical issues, and statistical methodology for designing and evaluating bridging studies and multiregional clinical trials, with the goal of inspiring new research activities in the field.
By Biotech Support Group
Cleanascite™ for lipid removal and identification of biomarkers for environmental contamination from fish bile samples containing metalloproteinases
By Rosa & Co
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012
By Rosa & Co
Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012.
By Alex Durand-Salmon
Banook, a leading clinical trial service provider, is pleased to announce the launch of Banook Central Imaging (, a global service organization providing medical imaging services for clinical research area.
By Rosa & Co
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012.
By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer.
By Rosa & Co
Series of Seminars and Workshops to be held in 2012 across the US and in Europe
By Impuls Public Relations OG
Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.
By Cambridge Healthtech Institute
Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.
By Biopontis Alliance
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity
By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.
By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.
By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.
By ValueNotes
Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&D) services such as drug development and clinical trials through strategic third-party collaborative partnerships.
By Cambridge Healthtech Institute
Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference
By ReportsnReports
Business Insight’s new report “New Emerging R&D Locations” is now available at
By Cambridge Healthtech Institute
Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).
By ReportsnReports
Espicom Limited’s new report “Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug Development” is now available at
By Camrbridge Healthtech Institute
Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!
By ReportsnReports
Kalorama Information’s new report “Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market” is now available at
By SMi Group
Paediatric vaccine development: Some key clinical trials - their design, execution and ethics
By Rosa & Co
Integration Creates Seamless Data Management and Analysis Capability for ARA Customers
By Reportsnreports
Business Monitor International ‘s “Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)” is now available at
By Melbourn Scientific
New award at DDL22 recognises the contribution of young people to the pharmaceutical industry.
By Ashley Rowe
IQPC’s 7th Annual Compound Management & Integrity Summit brings together Pharmaceutical Professionals, Clinical Research Organizations and Industry Experts to address evolving industry concerns
Holders of the IND for new products i.e. the Sponsors. Also, Principal Investigators and sub investigators, Clinical Research Scientists Safety Nurses, Clinical Research Associates and Coordinators , Recruiting staff, QA / QC auditors and staff.
By SMi Group Ltd
SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.
By Ashley Rowe
IQPC’s Pharmacovigilance North America Summit brings together industry experts to address top industry concerns
By SMi Group
Biobanking - Collaborating for Global R&D and Investment 11th & 12th July 2011 Crowne Plaza - The City, London, UK
By Luminovas
Niiki Pharma will present Phase I clinical study data for its transferrin targeted ruthenium based anti-cancer compound, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.
By Stephanie Flynn
Galera Therapeutics today announced Dr. Robert (Al) Beardsley as its new Chief Executive Officer.
By Dave Karasic, J.D.
The Boston-area formulation development CRO Integral BioSystems, LLC announces tradeshow presence at key pharmaceutical and biotech conferences, as part of its strategy to increase visibility.

Page updated every 10 minutes

Like PRLog?
Click to Share